NCT Id | NCT04107961 |
---|---|
Title | A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL) |
Condition | Post-kala-azar Dermal Leishmaniasis |
StudyType | Interventional |
Organization | University of York |
Sponsor/Collaborators | University of York |
Status | Not yet recruiting |
Gender | All |
AgeGroup | Child Adult |
Location (with distance) | |
Description | The LEISH3 trial is a randomised, controlled, double blind Phase II clinical trial to evaluate the safety and efficacy of vaccination with ChAd63-KH in the prevention of post-kala azar dermal leishmaniasis (PKDL) in Sudanese visceral leishmaniasis (VL) patients previously treated with sodium stibogluconate / paromomycin (SSG / PM). |